SCHEMBL2765646

SCHEMBL2765646

Cc1cc(N2CC(NC(=O)Oc3ccc(Br)s3)CC2=O)ccc1C(=O)N1CCCC(O)C1

nearest known ligand 0.43

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.43
POLB P06746 1/20 0.43
TP53 P04637 3/20 0.38
PIK3CA P42336 1/20 0.35
MTOR P42345 1/20 0.35
KDM4E B2RXH2 1/20 0.35
MAPT P10636 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2765966 0.92 LMNA (0.43) LMNAPOLBTP53KDM4EMAPT
SCHEMBL2766124 0.92 LMNA (0.44) LMNAPOLBTP53KDM4EMAPT
SCHEMBL2768063 0.91 LMNA (0.42) LMNAPOLBTP53KDM4EMAPT
SCHEMBL2767137 0.91 LMNA (0.46) LMNAPOLBTP53KDM4EMAPT
SCHEMBL2765569 0.91 LMNA (0.46) LMNAPOLBTP53KDM4EMAPT
SCHEMBL2765619 0.89 POLB (0.41) LMNAPOLBTP53MAPT
SCHEMBL2767009 0.88 LMNA (0.41) LMNAPOLBTP53KDM4EMAPT
SCHEMBL2767007 0.88 LMNA (0.40) LMNAPOLBTP53MAPT
SCHEMBL2766681 0.88 LMNA (0.42) LMNAPOLBTP53KDM4EMAPT
SCHEMBL2766741 0.88 POLB (0.41) LMNAPOLBTP53KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1858890-B1 NOVEL ANTITHROMBOTIC SUBSTITUTED PYRROLIDINONES, THE PRODUCTION AND USE THEREOF IN THE FORM OF MEDICAMENTS BOEHRINGER INGELHEIM PHARMA (DE) 2010-04-14 EP disclosed
EP-1858890-A1 NOVEL ANTITHROMBOTIC SUBSTITUTED PYRROLIDINONES, THE PRODUCTION AND USE THEREOF IN THE FORM OF MEDICAMENTS Boehringer Ingelheim Pharma GmbH & Co. KG (DE) 2007-11-28 EP disclosed
WO-2006089909-A1 NOVEL ANTITHROMBOTIC SUBSTITUTED PYRROLIDINONES, THE PRODUCTION AND USE THEREOF IN THE FORM OF MEDICAMENTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2006-08-31 WO disclosed